Skip to content
10-Q/A

Quarterly Report

GeneThera, Inc.

0001654954-20-012649

← back to feed
Filed
Nov 18, 2020 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 16, 2020 24.07M sh
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$5.31K
Operating Cash Flow Q3 2020 · Sep 30, 2019 $135.06K
Stockholders Equity restated Q3 2020 · Sep 30, 2020 −$7.52M
Stockholders Equity restated Q3 2020 · Jun 30, 2020 −$7.26M
Stockholders Equity Q3 2020 · Dec 31, 2019 −$6.92M
Stockholders Equity Q3 2020 · Sep 30, 2019 −$8.21M
Stockholders Equity Q3 2020 · Jun 30, 2019 −$8.25M
Stockholders Equity Q3 2020 · Dec 31, 2018 −$7.93M
Current Liabilities Q3 2020 · Sep 30, 2020 $7.54M
Current Liabilities Q3 2020 · Dec 31, 2019 $6.94M
Total Liabilities Q3 2020 · Sep 30, 2020 $7.54M
Total Liabilities Q3 2020 · Dec 31, 2019 $6.94M
Current Assets Q3 2020 · Sep 30, 2020 $12.32K
Current Assets Q3 2020 · Dec 31, 2019 $5.31K
Total Assets Q3 2020 · Sep 30, 2020 $24.2K
Total Assets Q3 2020 · Dec 31, 2019 $21.15K
Net Income Q3 2020 · Sep 30, 2020 −$274.37K
Net Income Q3 2020 · Sep 30, 2020 −$613.43K
Net Income Q3 2020 · Sep 30, 2019 $36.25K
Net Income Q3 2020 · Sep 30, 2019 −$278.5K
Operating Income Q3 2020 · Sep 30, 2020 −$272.72K
Operating Income Q3 2020 · Sep 30, 2020 −$608.49K
Operating Income Q3 2020 · Sep 30, 2019 −$204.33K
Operating Income Q3 2020 · Sep 30, 2019 −$500.05K